Skip to content
Medical Health Aged Care, Science

New technology, ‘Invasion-Block’, targets melanoma spread

Centenary Institute 2 mins read

Research conducted at the Centenary Institute has given rise to a ground-breaking tool called 'Invasion-Block' that can identify drugs capable of halting the spread of cancer cells. The pioneering development could lead to better treatments for melanoma, the most dangerous form of skin cancer.

 

An automated high-content screening platform, ‘Invasion-Block’ is designed to measure the invasive capacity of cancer cells. A revolutionary tool, it enables scientists to assess how well various drugs and compounds can prevent the spread of cancer.

 

In the recently published study, ‘Invasion-Block’ was employed to investigate the invasive behaviour of melanoma cells, particularly their ability to infiltrate other parts of the body. It was used in conjunction with a custom-designed image analysis program called ‘S-MARVEL’, to screen thousands of compounds, including drugs that are already approved for use in people.

 

Dr Shweta Tikoo, senior study researcher affiliated with both the Centenary Institute and the Department of Dermatology, Medical University of Vienna said that melanoma is an extremely challenging disease.

 

“Melanoma is a tough opponent, often spreading rapidly and making it difficult to treat. The key to finding better treatments lies in drug discovery and this is where the ‘Invasion-Block’ tool plays a pivotal role,” said Dr Tikoo.

 

Excitingly for the researchers, ‘Invasion Block’ revealed that drugs that blocked a class of enzymes – known as Abl/Src, PKC, PI3K, and ATM kinases – made melanoma cells much less able to invade other tissues.

 

“This suggests these enzymes may hold the key to finding treatments that can help curb the spread of melanoma,” said Dr Dajiang Guo, the first author of the study, currently a postdoctoral researcher at the Weill Cornell Medicine.

 

Intriguingly, the researchers further used CRISPR technology to ‘turn-off’ the gene responsible for expressing ATM kinase in melanoma cells. In doing so they observed that the melanoma cells became less invasive in laboratory tests and didn't spread as much to the lymph nodes when tested in mice.

 

“We believe that ATM may serve as a potent therapeutic target for treating the spread of melanoma in patients,” said Dr Tikoo.

 

The researchers say the study is a significant step in the fight against melanoma, offering fresh hope to patients while laying the groundwork for further studies and the development of new and better treatments.

 

“The combination of ‘Invasion-Block’ and ‘S-MARVEL’ is opening new avenues in the search for drugs that can arrest the spread of cancer,” said Dr Tikoo.

 

The study was co-headed by Dr Rohit Jain, Professor Wolfgang Weninger and Dr Shweta Tikoo with all three senior authors being co-affiliated with the Centenary Institute and the Medical University of Vienna.

 

The research was published in The Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences.

 

[ENDS]

 


Key Facts:

Publication:

Invasion-Block & S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.

https://www.pnas.org/doi/10.1073/pnas.2303978120


About us:

About the Centenary Institute

The Centenary Institute is a world-leading independent medical research institute, closely affiliated to the University of Sydney and the Royal Prince Alfred Hospital. Our research spans the critical areas of cancer, cardiovascular disease, rare diseases, inflammation, infectious diseases, healthy ageing and biomedical AI. Our strength lies in uncovering disease mechanisms and applying this knowledge to improve diagnostics and treatments for patients.

 

For more information about the Centenary Institute, visit centenary.org.au


Contact details:

For all media and interview enquiries, please contact

Tony Crawshaw, Media and Communications Manager, Centenary Institute on 0402 770 403 or email: [email protected]

Media

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 16/11/2026
  • 08:20
Cancer Council ACT

Cancer Council ACT marks 45 years of Slip! Slop! Slap! by encouraging sun-safe habits that last a lifetime

Little Sid Seagull lands in Canberra to help a new generation stay SunSmart. As Australia marks National Skin Cancer Action Week (NSCAW) from 15 – 22 November, Cancer Council ACT is encouraging Canberrans to build sun-safe habits that last a lifetime, with the return of beloved sun safety icon Sid Seagull and a renewed focus on protecting generations now and into the future from skin cancer. This year marks 45 years since Australians first met Sid Seagull through the iconic Slip! Slop! Slap! Campaign. Cancer Council ACT CEO, Verity Hawkins, said while progress has been made, skin cancer remains one…

  • Government QLD, Medical Health Aged Care
  • 16/11/2026
  • 07:15
Doctors for the Environment

Doctors and parents urge Queensland Government to reverse diesel bus decision over health risks

16 November 2026 Doctors and parent groups are urging the Crisafulli Government to reconsider its decision to abandon plans to electrify the public bus fleet and instead buy up to 630 new diesel buses, warning the move will prolong exposure to harmful air pollution and add to climate emissions. The call from Doctors for the Environment Australia (QLD), AMA Queensland and Parents for Climate comes ahead of this week’s parliamentary sitting. The groups warn diesel exhaust contributes to respiratory and cardiovascular disease, with children particularly vulnerable to air pollution while their lungs are developing. Diesel emissions also contribute to climate…

  • Medical Health Aged Care
  • 15/11/2026
  • 11:59
Royal Australian College of GPs

RACGP calls for GPs to be central to NSW Health@Home rollout

The Royal Australian College of GPs (RACGP) has welcomed the NSW Government's planned Health@Home service, while urging policymakers to ensure general practice is fully integrated and appropriately resourced as the program is rolled out. The NSW Government has committed $259 million to deliver hospital-level care at home across the state. Once fully operational, the service is expected to support around 76,000 patients annually and create capacity equivalent to 700 hospital beds. RACGP NSW & ACT Chair Dr Rebekah Hoffman said care at home could offer significant benefits for patients, provided it remains safe, voluntary and closely connected to a patient's…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.